Shenzhen King Explorer Science and Technology Past Earnings Performance
Past criteria checks 4/6
Shenzhen King Explorer Science and Technology's earnings have been declining at an average annual rate of -1.3%, while the Chemicals industry saw earnings growing at 8.4% annually. Revenues have been growing at an average rate of 28% per year. Shenzhen King Explorer Science and Technology's return on equity is 7%, and it has net margins of 7%.
Key information
-1.3%
Earnings growth rate
-8.1%
EPS growth rate
| Chemicals Industry Growth | 12.1% |
| Revenue growth rate | 28.0% |
| Return on equity | 7.0% |
| Net Margin | 7.0% |
| Last Earnings Update | 31 Mar 2024 |
Recent past performance updates
Recent updates
Shenzhen King Explorer Science and Technology's (SZSE:002917) Strong Earnings Are Of Good Quality
Apr 26
Capital Allocation Trends At Shenzhen King Explorer Science and Technology (SZSE:002917) Aren't Ideal
Apr 04Earnings Tell The Story For Shenzhen King Explorer Science and Technology Corporation (SZSE:002917) As Its Stock Soars 31%
Mar 08Revenue & Expenses BreakdownBeta
How Shenzhen King Explorer Science and Technology makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 31 Mar 24 | 1,580 | 111 | 267 | 82 |
| 31 Dec 23 | 1,507 | 102 | 256 | 79 |
| 30 Sep 23 | 1,340 | 59 | 249 | 79 |
| 30 Jun 23 | 1,286 | 47 | 242 | 79 |
| 31 Mar 23 | 1,228 | 31 | 225 | 80 |
| 01 Jan 23 | 1,193 | 25 | 212 | 76 |
| 30 Sep 22 | 1,190 | 41 | 182 | 73 |
| 30 Jun 22 | 1,062 | 26 | 160 | 65 |
| 31 Mar 22 | 884 | 28 | 132 | 57 |
| 01 Jan 22 | 815 | 40 | 115 | 56 |
| 30 Sep 21 | 707 | 53 | 83 | 49 |
| 30 Jun 21 | 678 | 67 | 82 | 48 |
| 31 Mar 21 | 705 | 72 | 87 | 51 |
| 31 Dec 20 | 633 | 69 | 80 | 45 |
| 30 Sep 20 | 583 | 71 | 88 | 40 |
| 30 Jun 20 | 531 | 70 | 79 | 38 |
| 31 Mar 20 | 455 | 62 | 71 | 34 |
| 31 Dec 19 | 452 | 61 | 71 | 34 |
| 30 Sep 19 | 448 | 66 | 71 | 33 |
| 30 Jun 19 | 421 | 66 | 68 | 30 |
| 31 Mar 19 | 415 | 64 | 69 | 29 |
| 31 Dec 18 | 418 | 65 | 66 | 29 |
| 30 Sep 18 | 417 | 63 | 58 | 27 |
| 30 Jun 18 | 426 | 64 | 45 | 36 |
| 31 Mar 18 | 419 | 61 | 43 | 30 |
| 31 Dec 17 | 432 | 63 | 48 | 25 |
| 30 Sep 17 | 430 | 66 | 60 | 14 |
| 30 Jun 17 | 473 | 76 | 74 | 0 |
| 31 Mar 17 | 451 | 64 | 75 | 0 |
| 31 Dec 16 | 456 | 62 | 75 | 0 |
| 31 Dec 15 | 399 | 73 | 77 | 0 |
| 31 Dec 14 | 320 | 29 | 56 | 0 |
| 31 Dec 13 | 207 | 14 | 40 | 0 |
Quality Earnings: 002917 has high quality earnings.
Growing Profit Margin: 002917's current net profit margins (7%) are higher than last year (2.5%).
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 002917's earnings have declined by 1.3% per year over the past 5 years.
Accelerating Growth: 002917's earnings growth over the past year (261.5%) exceeds its 5-year average (-1.3% per year).
Earnings vs Industry: 002917 earnings growth over the past year (261.5%) exceeded the Chemicals industry -19.7%.
Return on Equity
High ROE: 002917's Return on Equity (7%) is considered low.